Growth Metrics

Angiodynamics (ANGO) Change in Cash (2016 - 2026)

Angiodynamics' Change in Cash history spans 17 years, with the latest figure at -$3.8 million for Q1 2026.

  • For Q1 2026, Change in Cash rose 58.97% year-over-year to -$3.8 million; the TTM value through Feb 2026 reached -$7.0 million, up 79.37%, while the annual FY2025 figure was -$20.2 million, 164.14% down from the prior year.
  • Change in Cash reached -$3.8 million in Q1 2026 per ANGO's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $17.6 million in Q1 2024 to a low of -$21.1 million in Q3 2024.
  • Average Change in Cash over 5 years is $207000.0, with a median of $254000.0 recorded in 2023.
  • The largest YoY upside for Change in Cash was 6811.42% in 2024 against a maximum downside of 262.36% in 2024.
  • A 5-year view of Change in Cash shows it stood at $5.3 million in 2022, then plummeted by 37.46% to $3.3 million in 2023, then plummeted by 127.67% to -$916000.0 in 2024, then soared by 413.97% to $2.9 million in 2025, then tumbled by 233.1% to -$3.8 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Change in Cash are -$3.8 million (Q1 2026), $2.9 million (Q4 2025), and -$17.1 million (Q3 2025).